Inhibrx Biosciences Inc. (INBX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Inhibrx Biosciences Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -8.74x | 0.13x | -7.42x | -6.80x | -20.30x | -11.01x |
| P/B Ratio | 153.07x | 1.67x | 41.17x | 17.02x | 31.69x | 11.04x |
| P/S Ratio | 941.13x | 1114.64x | 994.97x | 450.85x | 232.97x | 65.03x |
| Profitability | ||||||
| Gross Margin | -91.0% | -1042.5% | 33.8% | -4926.7% | 62.3% | -473.8% |
| Operating Margin | -10386.5% | -165724.0% | -12178.9% | -5890.4% | -1074.6% | -526.6% |
| Net Margin | -10773.5% | 843786.0% | -13408.9% | -6625.3% | -1147.6% | -590.5% |
| EBITDA Margin | -10195.5% | 851675.0% | -11482.9% | -5739.8% | -1057.8% | -498.1% |
| Liquidity | ||||||
| Current Ratio | 3.93x | 3.94x | 5.25x | 10.17x | 6.20x | 4.21x |
| Quick Ratio | 3.93x | 3.94x | 5.25x | 10.17x | 6.23x | 8.33x |
| Leverage | ||||||
| Debt/Equity | 13.39x | 0.06x | 4.83x | 3.57x | 1.38x | 0.50x |
YoY = year-over-year change. Source: FMP..